يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Eriksson, Jan W."', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Diamanti , K , Cavalli , M , Pereira , M J , Pan , G , Castillejo-López , C , Kumar , C , Mundt , F , Komorowski , J , Deshmukh , A S , Mann , M , Korsgren , O , Eriksson , J W & Wadelius , C 2022 , ' Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues ' , Cell Reports Medicine , vol. 3 , no. 10 , 100763 . https://doi.org/10.1016/j.xcrm.2022.100763Test

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية

    المصدر: Dipta , P , Sarsenbayeva , A , Shmuel , M , Forno , F , Eriksson , J W , Pereira , M J , Abalo , X M , Wabitsch , M , Thaysen-Andersen , M & Tirosh , B 2021 , ' Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes ' , Comprehensive Psychoneuroendocrinology , vol. 7 , 100073 , pp. 1-13 . https://doi.org/10.1016/j.cpnec.2021.100073Test

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المصدر: Mulder , S , Hammarstedt , A , Nagaraj , S B , Nair , V , Ju , W , Hedberg , J , Greasley , P J , Eriksson , J W , Oscarsson , J & Heerspink , H J L 2020 , ' A metabolomics based molecular pathway analysis for how the SGLT2-inhibitor dapagliflozin may slow kidney function decline in patients with diabetes ' , Diabetes obesity & metabolism , vol. 22 , no. 7 , pp. 1157-1166 . https://doi.org/10.1111/dom.14018Test

    وصف الملف: application/pdf

  4. 4
    دورية أكاديمية

    المصدر: Mosenzon , O , Blicher , T M , Rosenlund , S , Eriksson , J W , Heller , S , Hels , O H , Pratley , R , Sathyapalan , T , Desouza , C , PIONEER 5 Investigators , Abramof , R , Alpenidze , D , Aronoff , S , Astamirova , K , Barker , B , Bedel , G , Belousova , L , Benson , M , Beshay , I , Biggs , W , Blaze , K , Bogdanski , P , Busch , R , Chaidarun , S , ....

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المصدر: Persson , F , Bodegard , J , Lahtela , J T , Nyström , T , Jørgensen , M E , Jensen , M L , Gulseth , H L , Thuresson , M , Hoti , F , Nathanson , D , Norhammar , A , Birkeland , K I , Eriksson , J G & Eriksson , J W 2018 , ' Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic) : A multinational observational study ' , Endocrinology, Diabetes & Metabolism , vol. 1 ....

    وصف الملف: application/pdf

  6. 6
    دورية أكاديمية

    المصدر: Mosenzon , O , Blicher , T M , Rosenlund , S , Eriksson , J W , Heller , S , Hels , O H , Pratley , R , Sathyapalan , T , Desouza , C & PIONEER 5 Investigators 2019 , ' Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5) : a placebo-controlled, randomised, phase 3a trial ' , The Lancet Diabetes & Endocrinology , vol. 7 , no. 7 , pp. 515-527 . https://doi.org/10.1016/S2213-8587Test(19)30192-5

  7. 7
    دورية أكاديمية

    المصدر: Birkeland , K I , Jørgensen , M E , Carstensen , B , Persson , F , Gulseth , H L , Thuresson , M , Fenici , P , Nathanson , D , Nyström , T , Eriksson , J W , Bodegård , J & Norhammar , A 2017 , ' Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic) : a multinational observational analysis ' , The Lancet Diabetes and Endocrinology , vol. 5 , no. 9 , pp. 709-717 . https://doi.org/10.1016/S2213-8587Test(17)30258-9